68Ga-DOTA-JR11
Showing 1 - 25 of 4,820
Neuroendocrine Tumors Trial in New York (PET/CT Imaging, 68Ga-DOTA-JR11, 177Lu-DOTA-JR11)
Completed
- Neuroendocrine Tumors
- PET/CT Imaging
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2022
Tumor-Induced Osteomalacia Trial in Beijing (68Ga-Dotatate, 68Ga-DOTA-JR11)
Recruiting
- Tumor-Induced Osteomalacia
- 68Ga-Dotatate
- 68Ga-DOTA-JR11
-
Beijing, Dongcheng, ChinaPeking union medical college hospital
Jan 2, 2021
Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)
Completed
- Neuroendocrine Tumors
-
Innsbruck, AustriaDepartment of Nuclear Medicine, Medical University of Innsbruck
Nov 24, 2023
Neuroendocrine Tumors Trial in Beijing (68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 PET/CT, 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 PET/CT)
Recruiting
- Neuroendocrine Tumors
- 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 PET/CT
- 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 3, 2020
Tumor, Solid Trial in Beijing (68Ga-DOTA-F2 PET/CT and 18F-FDG)
Recruiting
- Tumor, Solid
- 68Ga-DOTA-F2 PET/CT and 18F-FDG
-
Beijing, Beijing, ChinaPeking union medical college hospital
Nov 27, 2022
Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,
Recruiting
- Ganglioneuroblastoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Metastatic Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Sacramento ([68Ga]Ga DOTA-5G and [177Lu]Lu
Recruiting
- Metastatic Pancreatic Cancer
- Locally Advanced Pancreatic Adenocarcinoma
- [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.
-
Sacramento, CaliforniaUniversity of California Davis
Apr 21, 2022
Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)
Recruiting
- Prostate Cancer
- PET/CT
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of China University of Science and
Jul 19, 2023
Neuroendocrine Tumors Trial in Sherbrooke (68Ga-DOTA-TATE)
Recruiting
- Neuroendocrine Tumors
- 68Ga-DOTA-TATE
-
Sherbrooke, Quebec, CanadaCHUS
Jul 18, 2022
Prostate Cancer Trial in Stanford (68Ga RM2, 68Ga-PSMA-11, Investigational PET scanner coils and software)
Suspended
- Prostate Cancer
- 68Ga RM2
- +2 more
-
Stanford, CaliforniaStanford University
May 3, 2022
Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography
Recruiting
- Hepatocellular Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)
Recruiting
- Prostate Cancer Metastatic
-
Peking, ChinaPeking Union Medical College Hospital
Nov 25, 2022
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy
Enrolling by invitation
- Castration-Resistant Prostate Carcinoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)
Recruiting
- Prostate Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 1, 2022
Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)
Suspended
- Biochemically Recurrent Prostate Carcinoma
- Gallium Ga 68-labeled PSMA-11
- Positron Emission Tomography
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Tumor, Solid Trial in Xiamen (68Ga-DOTA-hLAG-3 PET/CT)
Recruiting
- Tumor, Solid
- 68Ga-DOTA-hLAG-3 PET/CT
-
Xiamen, Fujian, ChinaThe First affiliated hospital of xiamen university
May 8, 2022
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Turku, FinlandTurku University Hospital, Turku PET Centre
May 3, 2022
Glioma, Malignant, Glioma Glioblastoma Multiforme Trial in Warsaw ([68Ga]Ga-PSMA-11 PET/CT)
Completed
- Glioma, Malignant
- Glioma Glioblastoma Multiforme
- [68Ga]Ga-PSMA-11 PET/CT
-
Warsaw, Mazowieckie, PolandNuclear Medicne Department Medical University of Warsaw
May 29, 2023
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Prostate Cancer Trial in Stanford (drug, device, procedure)
Suspended
- Prostate Cancer
- 68-Ga RM2
- +3 more
-
Stanford, CaliforniaStanford University
May 3, 2022
Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)
Recruiting
- Neuroendocrine Tumors
- Gallium-68 NODAGA-JR11
-
Beijing, Beijing, China
- +1 more
Jul 27, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Terminated
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022
Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma Trial in Rochester (radiation, drug, procedure, other)
Recruiting
- Grade 1 Meningioma
- +4 more
- Gallium Ga 68-DOTATATE
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023